Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations

P. J. Morrison, C. M. Steel, N. C. Nevin, D. G. Evans, D. M. Eccles, H. Vasen, P. Møller, S. Hodgson, D. Stoppa-Lyonnet, J. Chang-Claude, M. Caligo, E. Oláh, N. E. Haites

Research output: Article

6 Citations (Scopus)

Abstract

We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.

Original languageEnglish
Pages (from-to)272-277
Number of pages6
JournalCME Journal of Gynecologic Oncology
Volume5
Issue number3
Publication statusPublished - 2000

Fingerprint

Insurance
Breast Neoplasms
Genetic Testing
Legislation
Counseling
Neoplasms
Economics
Guidelines

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Morrison, P. J., Steel, C. M., Nevin, N. C., Evans, D. G., Eccles, D. M., Vasen, H., ... Haites, N. E. (2000). Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations. CME Journal of Gynecologic Oncology, 5(3), 272-277.

Insurance considerations for individuals with a high risk of breast cancer in Europe : Some recommendations. / Morrison, P. J.; Steel, C. M.; Nevin, N. C.; Evans, D. G.; Eccles, D. M.; Vasen, H.; Møller, P.; Hodgson, S.; Stoppa-Lyonnet, D.; Chang-Claude, J.; Caligo, M.; Oláh, E.; Haites, N. E.

In: CME Journal of Gynecologic Oncology, Vol. 5, No. 3, 2000, p. 272-277.

Research output: Article

Morrison, PJ, Steel, CM, Nevin, NC, Evans, DG, Eccles, DM, Vasen, H, Møller, P, Hodgson, S, Stoppa-Lyonnet, D, Chang-Claude, J, Caligo, M, Oláh, E & Haites, NE 2000, 'Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations', CME Journal of Gynecologic Oncology, vol. 5, no. 3, pp. 272-277.
Morrison, P. J. ; Steel, C. M. ; Nevin, N. C. ; Evans, D. G. ; Eccles, D. M. ; Vasen, H. ; Møller, P. ; Hodgson, S. ; Stoppa-Lyonnet, D. ; Chang-Claude, J. ; Caligo, M. ; Oláh, E. ; Haites, N. E. / Insurance considerations for individuals with a high risk of breast cancer in Europe : Some recommendations. In: CME Journal of Gynecologic Oncology. 2000 ; Vol. 5, No. 3. pp. 272-277.
@article{6163be84c6e041d7aec8594ccf40ddcb,
title = "Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations",
abstract = "We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.",
keywords = "Genetic testing, Guidelines, Insurance",
author = "Morrison, {P. J.} and Steel, {C. M.} and Nevin, {N. C.} and Evans, {D. G.} and Eccles, {D. M.} and H. Vasen and P. M{\o}ller and S. Hodgson and D. Stoppa-Lyonnet and J. Chang-Claude and M. Caligo and E. Ol{\'a}h and Haites, {N. E.}",
year = "2000",
language = "English",
volume = "5",
pages = "272--277",
journal = "CME Journal of Gynecologic Oncology",
issn = "1219-9087",
publisher = "Primed-X Press",
number = "3",

}

TY - JOUR

T1 - Insurance considerations for individuals with a high risk of breast cancer in Europe

T2 - Some recommendations

AU - Morrison, P. J.

AU - Steel, C. M.

AU - Nevin, N. C.

AU - Evans, D. G.

AU - Eccles, D. M.

AU - Vasen, H.

AU - Møller, P.

AU - Hodgson, S.

AU - Stoppa-Lyonnet, D.

AU - Chang-Claude, J.

AU - Caligo, M.

AU - Oláh, E.

AU - Haites, N. E.

PY - 2000

Y1 - 2000

N2 - We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.

AB - We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.

KW - Genetic testing

KW - Guidelines

KW - Insurance

UR - http://www.scopus.com/inward/record.url?scp=0034520279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034520279&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034520279

VL - 5

SP - 272

EP - 277

JO - CME Journal of Gynecologic Oncology

JF - CME Journal of Gynecologic Oncology

SN - 1219-9087

IS - 3

ER -